RapidTrials published longitudinal data from Berine Metabolic to examine evidence alignment and traditional support models in low-carb diabetes care.
Public source
Publisher name
Public post
"Low-carb works, but patients can't stick to it." We hear this narrative constantly in diabetes care, so the team at Berine Metabolic dug into the longitudinal data to s…
Company
RapidTrials
It's about time.
- Industry
- Biotechnology Research
- Location
- Wainscott, US
- Company size
- 11–50 employees
About RapidTrials
RapidTrials uses our experience and deep life science and healthcare industry relationships to boost site and study performance. Using tested evidence-based methods to strategically assemble the finest talent and teams in the industry, we produce measurable results that matter, expediting patient access to groundbreaking treatments. With access to tens of thousands of specialized life sciences and healthcare providers, we carefully screen candidates based on your needs, ensuring that they are being met by talent with the right skills and experience—temporary contractors, direct hires, or part-time and full-time staff. Principal investigators Sub-investigators Research nurses, study nurses, nurse practitioners Clinical research coordinators Research pharmacists Psychometricians Patient recruitment and retention specialists Patient escorts Social workers, physical therapists, respiratory therapists, nutritionists Clinical data coordinators Data abstractors Healthcare professionals
See moreLatest activity
Latest activity from RapidTrials
3 signals
Operations & Supply
RapidTrials has intentionally kept its role simple in clinical trials, allowing the site to select and direct qualified CRCs, research nurses, data coordinators, and protocol-specific resources.
Partnerships
RapidTrials worked with the board and Dr Maready to get state support in Obesity Medicine coming this year.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Kailera Therapeutics
Kailera Therapeutics published a new preprint on real-world GLP-1/GIP use in the US, highlighting that Incretin-Based Medications are used in the Wild, Wild West with significant growth and cross-sectional data.
Research & Knowledge
Flow Health Science
Flow Health Science published a new DiabeticMedicine editorial examining the growing mismatch between glucose monitoring and delivery technologies, and the relatively crude options still used to treat hypoglycaemia.
Research & Knowledge
Flourish Research
Flourish Research published a new report titled Four Trends in Obesity Clinical Trials exploring key themes related to patient retention and lifestyle support in obesity trials.
Research & Knowledge
Drug Hunter
Drug Hunter published recent Ph. 2b ACCESS data showing that Structure Therapeutics' aleniglipron entered a clinically meaningful weight loss phase with no apparent plateau at week 36 and continued weight reductions in the open-label extension.
Research & Knowledge
Keto-Mojo